RDY Total Assets from 2010 to 2024

RDY Stock

USD 14.08 0.06 0.42%

Dr Reddys Total Assets yearly trend continues to be fairly stable with very little volatility. Total Assets will likely drop to about 214.9 B in 2024. Total Assets is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. View All Fundamentals

Total Assets

First Reported

2000-03-31

Previous Quarter

415.3 B

Current Value

466 B

Quarterly Volatility

212.9 B

Dot-com Bubble

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Check Dr Reddys financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Dr Reddys' main balance sheet or income statement drivers, such as Interest Expense of 1.8 B, Total Revenue of 293.1 B or Gross Profit of 171.8 B, as well as many indicators such as Price To Sales Ratio of 3.91, Dividend Yield of 0.0061 or PTB Ratio of 3.89. RDY financial statements analysis is a perfect complement when working with Dr Reddys Valuation or Volatility modules.

Check out the analysis of Dr Reddys Correlation against competitors.

Latest Dr Reddys' Total Assets Growth Pattern

Below is the plot of the Total Assets of Dr Reddys Laboratories over the last few years. Total assets refers to the total amount of Dr Reddys assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Dr Reddys Laboratories books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. It is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. Dr Reddys' Total Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Dr Reddys' overall financial position and show how it may be relating to other accounts over time.

View

Last Reported 387.52 B

10 Years Trend

Very volatile

Compare to Others All Fundamentals

Total Assets

Timeline

RDY Total Assets Regression Statistics

	Arithmetic Mean	300,429,611,449
	Geometric Mean	158,504,715,481
	Coefficient Of Variation	107.50
	Mean Deviation	164,369,355,420
	Median	225,427,000,000
	Standard Deviation	322,973,050,686
	Sample Variance	104311591469.5T
	Range	1.4T
	R-Value	(0.08)
	Mean Square Error	111614409209.3T
	R-Squared	0.01
	Significance	0.78
	Slope	(5,786,363,542)
	Total Sum of Squares	1460362280573.4T

RDY Total Assets History

	2024	214.9 B
	2023	387.5 B
	2022	322.9 B
	2021	296.7 B
	2020	265.5 B
	2019	232.2 B
	2018	225.4 B

Other Fundumenentals of Dr Reddys Laboratories

Intangibles To Total Assets

Dr Reddys Total Assets component correlations

	Total Assets	Total Stockholder Equity	Retained Earnings	Accounts Payable	Long Term Debt	Short Term Investments	Total Liab	Intangible Assets	Common Stock	Property Plant Equipment	Current Deferred Revenue	Net Debt	Net Receivables	Good Will	Total Current Assets	Treasury Stock	Short Term Debt	Net Tangible Assets	Long Term Investments	Short Long Term Debt	Long Term Debt Total	Capital Surpluse	Cash And Equivalents	Net Invested Capital	Net Working Capital	Capital Stock
Total Assets		0.96	-0.06	0.99	-0.14	0.91	0.99	0.91	0.98	-0.16	-0.05	0.96	1.0	0.98	1.0	0.03	0.96	0.04	-0.08	0.19	-0.14	-0.18	0.11	0.03	0.02	-0.07
Total Stockholder Equity	0.96		0.19	0.94	-0.15	0.97	0.93	0.87	0.91	0.04	0.07	0.88	0.95	0.95	0.96	-0.16	0.89	0.16	0.03	0.07	-0.18	-0.11	0.14	0.23	0.21	0.18
Retained Earnings	-0.06	0.19		-0.15	0.09	0.21	-0.17	0.04	-0.22	0.87	0.7	-0.27	-0.08	-0.12	-0.04	-0.84	-0.26	0.68	0.65	-0.54	0.02	0.38	-0.1	0.83	0.85	0.56
Accounts Payable	0.99	0.94	-0.15		-0.13	0.89	1.0	0.9	0.99	-0.24	-0.16	0.98	0.99	0.99	0.99	0.13	0.98	-0.05	-0.16	0.26	-0.13	-0.22	0.15	-0.05	-0.07	-0.06
Long Term Debt	-0.14	-0.15	0.09	-0.13		-0.24	-0.13	0.19	-0.16	0.4	0.07	-0.06	-0.18	-0.15	-0.18	0.11	-0.16	0.0	0.21	-0.22	0.99	0.44	-0.49	-0.15	-0.14	-0.08
Short Term Investments	0.91	0.97	0.21	0.89	-0.24		0.88	0.77	0.87	-0.01	-0.01	0.81	0.91	0.91	0.92	-0.13	0.83	0.12	-0.1	-0.01	-0.28	-0.14	0.32	0.3	0.27	0.25
Total Liab	0.99	0.93	-0.17	1.0	-0.13	0.88		0.89	1.0	-0.26	-0.16	0.98	0.99	0.99	0.98	0.16	0.99	-0.09	-0.17	0.27	-0.14	-0.23	0.13	-0.09	-0.12	-0.06
Intangible Assets	0.91	0.87	0.04	0.9	0.19	0.77	0.89		0.86	0.08	0.03	0.9	0.89	0.88	0.88	0.02	0.87	0.07	0.14	0.17	0.18	-0.02	-0.09	0.0	0.0	-0.08
Common Stock	0.98	0.91	-0.22	0.99	-0.16	0.87	1.0	0.86		-0.31	-0.21	0.98	0.98	0.99	0.97	0.19	0.99	-0.14	-0.23	0.29	-0.17	-0.25	0.16	-0.14	-0.16	-0.04
Property Plant Equipment	-0.16	0.04	0.87	-0.24	0.4	-0.01	-0.26	0.08	-0.31		0.66	-0.31	-0.19	-0.22	-0.17	-0.7	-0.33	0.7	0.74	-0.48	0.36	0.68	-0.3	0.61	0.64	0.38
Current Deferred Revenue	-0.05	0.07	0.7	-0.16	0.07	-0.01	-0.16	0.03	-0.21	0.66		-0.22	-0.07	-0.13	-0.04	-0.86	-0.23	0.65	0.75	-0.42	0.08	0.34	-0.6	0.51	0.58	0.11
Net Debt	0.96	0.88	-0.27	0.98	-0.06	0.81	0.98	0.9	0.98	-0.31	-0.22		0.96	0.97	0.94	0.24	0.98	-0.15	-0.18	0.37	-0.06	-0.29	0.07	-0.19	-0.2	-0.1
Net Receivables	1.0	0.95	-0.08	0.99	-0.18	0.91	0.99	0.89	0.98	-0.19	-0.07	0.96		0.99	1.0	0.06	0.97	0.01	-0.13	0.19	-0.18	-0.19	0.13	0.0	0.0	-0.07
Good Will	0.98	0.95	-0.12	0.99	-0.15	0.91	0.99	0.88	0.99	-0.22	-0.13	0.97	0.99		0.98	0.1	0.98	-0.07	-0.15	0.24	-0.16	-0.21	0.14	-0.06	-0.08	0.02
Total Current Assets	1.0	0.96	-0.04	0.99	-0.18	0.92	0.98	0.88	0.97	-0.17	-0.04	0.94	1.0	0.98		0.01	0.95	0.06	-0.1	0.18	-0.19	-0.19	0.13	0.07	0.06	-0.06
Treasury Stock	0.03	-0.16	-0.84	0.13	0.11	-0.13	0.16	0.02	0.19	-0.7	-0.86	0.24	0.06	0.1	0.01		0.24	-0.82	-0.75	0.34	0.15	-0.25	0.3	-0.8	-0.83	-0.35
Short Term Debt	0.96	0.89	-0.26	0.98	-0.16	0.83	0.99	0.87	0.99	-0.33	-0.23	0.98	0.97	0.98	0.95	0.24		-0.19	-0.21	0.33	-0.16	-0.25	0.15	-0.19	-0.22	-0.06
Net Tangible Assets	0.04	0.16	0.68	-0.05	0.0	0.12	-0.09	0.07	-0.14	0.7	0.65	-0.15	0.01	-0.07	0.06	-0.82	-0.19		0.65	-0.16	-0.03	0.42	-0.26	0.75	0.8	0.06
Long Term Investments	-0.08	0.03	0.65	-0.16	0.21	-0.1	-0.17	0.14	-0.23	0.74	0.75	-0.18	-0.13	-0.15	-0.1	-0.75	-0.21	0.65		-0.04	0.19	0.27	-0.43	0.52	0.53	0.14
Short Long Term Debt	0.19	0.07	-0.54	0.26	-0.22	-0.01	0.27	0.17	0.29	-0.48	-0.42	0.37	0.19	0.24	0.18	0.34	0.33	-0.16	-0.04		-0.22	-0.57	0.08	-0.34	-0.38	-0.17
Long Term Debt Total	-0.14	-0.18	0.02	-0.13	0.99	-0.28	-0.14	0.18	-0.17	0.36	0.08	-0.06	-0.18	-0.16	-0.19	0.15	-0.16	-0.03	0.19	-0.22		0.46	-0.52	-0.23	-0.2	-0.16
Capital Surpluse	-0.18	-0.11	0.38	-0.22	0.44	-0.14	-0.23	-0.02	-0.25	0.68	0.34	-0.29	-0.19	-0.21	-0.19	-0.25	-0.25	0.42	0.27	-0.57	0.46		-0.27	0.12	0.14	0.05
Cash And Equivalents	0.11	0.14	-0.1	0.15	-0.49	0.32	0.13	-0.09	0.16	-0.3	-0.6	0.07	0.13	0.14	0.13	0.3	0.15	-0.26	-0.43	0.08	-0.52	-0.27		0.16	0.08	0.22
Net Invested Capital	0.03	0.23	0.83	-0.05	-0.15	0.3	-0.09	0.0	-0.14	0.61	0.51	-0.19	0.0	-0.06	0.07	-0.8	-0.19	0.75	0.52	-0.34	-0.23	0.12	0.16		0.98	0.34
Net Working Capital	0.02	0.21	0.85	-0.07	-0.14	0.27	-0.12	0.0	-0.16	0.64	0.58	-0.2	0.0	-0.08	0.06	-0.83	-0.22	0.8	0.53	-0.38	-0.2	0.14	0.08	0.98		0.27
Capital Stock	-0.07	0.18	0.56	-0.06	-0.08	0.25	-0.06	-0.08	-0.04	0.38	0.11	-0.1	-0.07	0.02	-0.06	-0.35	-0.06	0.06	0.14	-0.17	-0.16	0.05	0.22	0.34	0.27

Click cells to compare fundamentals

About Dr Reddys Financial Statements

Dr Reddys investors use historical fundamental indicators, such as Dr Reddys' Total Assets, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Dr Reddys. Please read more on our technical analysis and fundamental analysis pages.

	Last Reported	Projected for Next Year
Total Assets	387.5 B	214.9 B
Intangibles To Total Assets	0.11	0.20

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

ESRT	Empire State Realty
C	Citigroup
C	Citigroup

Additional Tools for RDY Stock Analysis

When running Dr Reddys' price analysis, check to measure Dr Reddys' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Dr Reddys is operating at the current time. Most of Dr Reddys' value examination focuses on studying past and present price action to predict the probability of Dr Reddys' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Dr Reddys' price. Additionally, you may evaluate how the addition of Dr Reddys to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC